Medtronic Ps Medical, Inc., a prominent player in the medical technology industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in the development of innovative solutions for patients with chronic conditions. With a focus on neuromodulation and advanced surgical technologies, Medtronic Ps Medical offers a range of core products, including implantable devices and therapeutic systems that enhance patient outcomes. The company operates extensively across North America and has a growing presence in Europe and Asia. Medtronic Ps Medical is recognised for its commitment to research and development, achieving significant milestones in patient care and safety. Its unique approach to integrating cutting-edge technology with patient-centric solutions has solidified its market position, making it a trusted name in the healthcare sector.
How does Medtronic Ps Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Medtronic Ps Medical, Inc.'s score of 50 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medtronic Ps Medical, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Medtronic plc, which may influence its climate commitments and emissions reporting. As part of its corporate family, Medtronic Ps Medical, Inc. inherits climate initiatives and targets from Medtronic plc. However, there are no documented reduction targets or specific climate pledges available for this subsidiary. The absence of emissions data and reduction initiatives suggests that Medtronic Ps Medical, Inc. may still be aligning its strategies with the broader goals set by its parent company. Medtronic plc has been active in addressing climate change, and any commitments or targets from this parent organisation may cascade down to Medtronic Ps Medical, Inc. through their corporate relationship. For detailed information on emissions and climate commitments, stakeholders may need to refer to Medtronic plc's disclosures and sustainability reports.
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | - |
Medtronic Ps Medical, Inc.'s Scope 3 emissions, which increased by 48% last year and increased by approximately 48% since 2021, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 55% of total emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the largest emissions source at 47% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medtronic Ps Medical, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.